MedTrace Logo

Simvastatin in Chronic Obstructive Pulmonary Disease (COPD)

NCT00680641 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2011-08-05

No results posted yet for this study

Summary

To determine the effects of 2 months therapy with simvastatin 40mg once per day compared to placebo in a double-blind placebo-controlled study of patients with COPD.

Conditions

Interventions

DRUG

Simvastatin

40mg of Simvastatin once daily

DRUG

Placebo

40mg of placebo once daily

Sponsors & Collaborators

  • University of East Anglia

    lead OTHER

Principal Investigators

  • Andrew M Wilson, MD, MRCP (UK) · Clinical Senior Lecturer, University of East Anglia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2011-02-28
Completion
2012-02-29

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00680641 on ClinicalTrials.gov